What tests are considered CLIA-waived?
CLIA-waived tests are simple, low-risk laboratory tests cleared by the FDA for home use or point-of-care settings that have a negligible risk of error if manufacturer instructions are followed.
Common Examples of CLIA-Waived Tests
- Blood glucose monitoring (using FDA-cleared handheld meters)
- Urine pregnancy tests (visual qualitative tests)
- Urinalysis (dipstick tests)
- Rapid strep and influenza (flu) tests
- Fecal occult blood tests (FOBT)
- Cholesterol and lipid screening (portable analyzers)
Finding the Full Official List
Because the official catalog contains over 1,400 individual test systems and is updated frequently, you can look up specific brand names, manufacturers, or analytes using the official FDA CLIA Database. You can also browse the current active list of analytes directly through the FDA Currently Waived Analytes reference.
What is considered a Clia waived test?
A CLIA-waived test is a simple laboratory examination or procedure that the FDA has determined has a low risk of incorrect results and minimal chance of patient harm if performed incorrectly.
Key Characteristics
- Simple Methodology: Uses straightforward procedures or automated steps that require little to no special interpretation by the operator.
- Low Risk: Poses negligible risk of harm to the patient or an incorrect diagnosis if done properly.
- Home or Over-the-Counter Use: Includes most tests cleared by the FDA for home or direct consumer use.
- Regulatory Exemption: Facilities performing only waived tests need a Certificate of Waiver and are exempt from routine on-site inspections or strict personnel qualification requirements. They must still strictly follow the manufacturer's instructions.
Common Examples
- Blood Glucose Monitors: Point-of-care testing for diabetes management.
- Urinalysis: Basic dipstick urine tests.
- Pregnancy Tests: Qualitative urine-based tests.
- Rapid Diagnostic Tests: Rapid antigen tests for strep throat, influenza, and COVID-19.
- Fecal Occult Blood: Stool tests for hidden blood.
What is not considered a Clia waived test?
Microscopic evaluations and any tests classified as moderate- or high-complexity are not considered CLIA-waived tests.
What Makes a Test Non-Waived?
The Centers for Disease Control and Prevention (CDC) explains that tests require specialized skills, precise calibration, or professional judgment to avoid errors. These are categorized as non-waived testing. They need strict quality controls and routine inspections.
Examples of Tests That Are NOT Waived
- Microscopic evaluations: Looking at slides under a microscope to find cells or bacteria requires training and expertise.
- Comprehensive chemistry panels: Standard blood tests that measure multiple chemical components using complex lab machines.
- Microbiology cultures: Growing and identifying bacteria or fungi from patient samples.
- Blood typing and compatibility testing: Crossmatching blood before a transfusion.
When a Waived Test Becomes Non-Waived
A simple test loses its waived status if a laboratory alters the process. If a clinic tests a different body fluid than the manufacturer allows or fails to follow the exact instructions, the test is treated as a high- or moderate-complexity test.
What will happen to CLIA-waived tests in 2026?
In 2026, CLIA-waived tests and the broader Clinical Laboratory Improvement Amendments program are transitioning to mandatory paperless digital operations, stricter payer enforcement, and updated coding guidelines.
Key Changes in 2026
- Paperless Certification Transition: Starting March 1, 2026, the Centers for Medicare & Medicaid Services (CMS) completely eliminated paper-based mailings for CLIA certificates, fee coupons, and program notifications. Facilities performing point-of-care or waived testing must manage communications and receive electronic certificates via email.
- Stricter Payer Enforcement ("Hard Stops"): Insurance payers are shifting toward automated verification, meaning missing or unverified CLIA information can trigger immediate claim rejections rather than preliminary warning notifications.
- Coding and Modifier Updates: CMS updates via rulings like MM14476 mandate the continued use of the QW modifier for specific waived lab testing claims under the Clinical Laboratory Fee Schedule.
- Quality Assurance Emphasis: Updated federal oversight frameworks continue to emphasize strict adherence to manufacturer package instructions, proper reagent handling, and test storage requirements for all Certificate of Waiver holders.
Is there a list of CLIA waived tests?
Yes, the U.S. Food and Drug Administration (FDA) maintains an official, searchable database listing all tests granted waived status.
Where to Find the List
- Official Database: You can search for specific test systems, manufacturers, or analytes using the FDA CLIA Database.
- Currently Waived Analytes: The CDC Waived Tests Overview provides regulatory background and guidance on tests that qualify for a Certificate of Waiver.
Common CLIA-Waived Tests
While the full database contains thousands of individual commercial test systems, common categories of waived tests include:
- Blood glucose monitoring devices
- Urine pregnancy tests (visual color comparison)
- Non-automated dipstick urinalysis
- Rapid strep and influenza tests
- COVID-19 rapid antigen tests
- Fecal occult blood tests (FOBT)
- Cholesterol and lipid screening
Perform a CLIA Waived Urinalysis Perform a Pregnancy Test
Which of the following tests would fall under CLIA waived status?
A CLIA-waived test is a simple, low-risk laboratory test that has been cleared by the FDA for home use or approved as so simple that the chance of an incorrect result is negligible.
Common Examples of CLIA-Waived Tests
- Blood glucose monitoring (sugar tests for diabetes)
- Urine pregnancy tests
- Dipstick urinalysis
- Rapid strep tests (throat swabs for strep throat)
- Rapid influenza (flu) tests
- Fecal occult blood tests (stool tests for blood)
Key Features
- Low Risk: They carry little risk of harm if done wrong, though you must still follow the maker's directions.
- Where They Are Used: You see them at point-of-care settings like doctor offices, retail clinics, pharmacies, and at home.
- Easy Rules: Facilities using these only need a simple Certificate of Waiver from the Centers for Medicare & Medicaid Services.
You can check if a specific diagnostic product is on the approved list using the FDA CLIA Database Search.
Is a pap smear a CLIA waived test?
No, a Pap test is not CLIA-waived.
Why It Is Not Waived
- High Complexity: A Papanicolaou (Pap) test is a cytology procedure that requires specialized microscopic examination and morphological assessment of cellular samples.
- Expert Interpretation: It requires trained professionals, such as cytotechnologists or pathologists, to analyze the slides accurately.
- Strict Regulation: Because it involves complex interpretation rather than a simple, automated, low-risk process, it falls under non-waived categories (moderate-to-high complexity) subject to specialized personnel and quality control rules.
Is a COVID test in a CLIA waived?
Many COVID-19 tests are CLIA-waived, but whether a specific test qualifies depends on its FDA authorization and the setting where it is used.
How to Tell If a Test Is CLIA-Waived
- Check the FDA Label: Look at the product's instructions or the FDA In Vitro Diagnostics EUAs database. Authorized point-of-care tests typically show a "W" in the column listing authorized settings.
- Point-of-Care (POC) Status: Many rapid antigen and molecular tests used in clinics, urgent care centers, and pharmacies are specifically authorized for patient-care settings operating under a CDC Point-of-Care Testing Guidance framework.
- At-Home Tests: Over-the-counter (OTC) self-tests used at home do not require a professional CLIA certificate to run personally, but any organization or workplace performing tests on employees or patients must operate under a valid CLIA Certificate of Waiver.
Is a hCG test in a Clia waived?
Yes, qualitative human chorionic gonadotropin (hCG) urine pregnancy tests are CLIA waived when performed according to the manufacturer's instructions.
Key Details About CLIA-Waived hCG Tests
- Sample Type: Only urine samples qualify for CLIA waiver status on these rapid point-of-care devices.
- Complexity Level: Serum (blood) hCG tests and quantitative blood tests are typically classified as moderately complex and require a standard or high-complexity CLIA certification.
- Test Purpose: These rapid visual tests are qualitative, meaning they detect whether hCG is present at or above a specific threshold (commonly 25 mIU/mL) to provide a positive or negative result.
- Regulatory Standard: Facilities performing only waived tests must still hold a Certificate of Waiver under the Clinical Laboratory Improvement Amendments (CLIA).
What is the difference between CLIA-waived and non-waived tests?
CLIA-waived tests are simple, low-risk diagnostics meant for minimal oversight, while non-waived tests cover moderate- to high-complexity procedures requiring strict regulatory compliance, inspections, and formal personnel qualifications.
The Centers for Disease Control and Prevention (CDC) and the Centers for Medicare & Medicaid Services (CMS) outline these differences based on test complexity.
Key Differences
| Feature | CLIA-Waived Tests | Non-Waived Tests |
|---|---|---|
| Complexity Level | Simple, low risk of incorrect results. | Moderate or high complexity. |
| Regulatory Oversight | Minimal; must follow manufacturer instructions. | Stringent; requires quality control, systems, and proficiency testing. |
| Certificate Type | Certificate of Waiver (CoW). | Certificate of Compliance or Accreditation (CoC/CoA). |
| Inspections | No routine inspections (occasional random checks). | Periodic mandatory inspections and surveys. |
| Personnel Requirements | No specific federal training or education mandated. | Strict educational and qualification standards for staff. |
| Common Examples | Urine pregnancy tests, home glucose meters, dipsticks. | Complete blood counts (CBC), thyroid panels, comprehensive chemistry. |